ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01269853
Brief Title: Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA

First Submitted : December 22, 2010
First Submitted that Met QC Criteria : January 3, 2011
First Posted : January 4, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : November 29, 2017
Last Update Posted : December 2, 2017